Skip to main navigation Skip to search Skip to main content

Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease

  • Brian Finan
  • , Christoffer Clemmensen
  • , Zhimeng Zhu
  • , Kerstin Stemmer
  • , Karine Gauthier
  • , Luisa Mueller
  • , Meri De Angelis
  • , Kristin Moreth
  • , Frauke Neff
  • , Diego Perez-Tilve
  • , Katrin Fischer
  • , Dominik Lutter
  • , Miguel A. Sanchez-Garrido
  • , Peng Liu
  • , Jan Tuckermann
  • , Mohsen Malehmir
  • , Marc E. Healy
  • , Achim Weber
  • , Mathias Heikenwalder
  • , Martin Jastroch
    • Maximilian Kleinert, Sigrid Jall, Sara Brandt, Frederic Flamant, Karl-Werner Schramm, Heike Biebermann, Yvonne Doering, Christian Weber, Kirk M. Habegger, Michaela Keuper, Vasily Gelfanov, Fa Liu, Josef Koehrle, Jan Rozman, Helmut Fuchs, Valerie Gailus-Durner, Martin Hrabe de Angelis, Susanna M. Hofmann, Bin Yang, Matthias H. Tschoep*, Richard DiMarchi*, Timo D. Mueller
*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease'. Together they form a unique fingerprint.
Sort by

Keyphrases

INIS

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Chemistry